Figure 5From: ARA290, a non-erythropoietic EPO derivative, attenuates renal ischemia/reperfusion injuryEffect of ARA290 on mRNA expression of markers of structural damage. qRT-PCR analyses show TGF-β and α-SMA mRNA expression at seven days post-reperfusion relative to contralateral kidney. ARA290 prevented an increase of TGF-β mRNA expression (p<0.05, 5A). A similar tendency was observed in α-SMA mRNA expression (5B).Back to article page